Cargando…
Virtual screening and activity evaluation of human uric acid transporter 1 (hURAT1) inhibitors
Hyperuricemia is a disease caused by disorder of purine metabolism, mainly due to insufficient renal excretion of uric acid. Urate transporter 1 (URAT1) is the most widely studied target of urate transporters, and used for uric acid (UA) reabsorption. This study used the AlphaFold2 algorithm to pred...
Autores principales: | Yang, Yacong, Hu, Yu, Yao, Fengli, Yang, Jinbo, Ge, Leilei, Wang, Peng, Xu, Ximing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871872/ https://www.ncbi.nlm.nih.gov/pubmed/36756549 http://dx.doi.org/10.1039/d2ra07193b |
Ejemplares similares
-
Discovery of a Flexible Triazolylbutanoic Acid as a Highly Potent Uric Acid Transporter 1 (URAT1) Inhibitor
por: Tian, He, et al.
Publicado: (2016) -
Discovery of URAT1 SNPs and association between serum uric acid levels and URAT1
por: Cho, Sung Kweon, et al.
Publicado: (2015) -
Mutation in Transmembrane
Domain 8 of Human Urate
Transporter 1 Disrupts Uric Acid Recognition and Transport
por: Lan, Qunsheng, et al.
Publicado: (2022) -
Urate transport capacity of glucose transporter 9 and urate transporter 1 in cartilage chondrocytes
por: Zhang, Bingqing, et al.
Publicado: (2019) -
Structural Insights into the Atomistic Mechanisms
of Uric Acid Recognition and Translocation of Human Urate Anion Transporter
1
por: Zhao, Ze’an, et al.
Publicado: (2020)